STAT5B and T-cell leukemia: Tyrosine 665 is the second most abundant mutational target in the STAT5B SH2 domain (Fig. 1A), with 12 T cell leukemia cases reported in the COSMIC database and 15 cases in the database of the Munich Leukemia Laboratory (MLL).